Home › Lipoid Nephrosis › Ohio
Lipoid Nephrosis clinical trials in Ohio
4 studies for Lipoid Nephrosis are looking for participants at sites in Ohio.
Cities in Ohio
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Cleveland Clinic - Cleveland- Site Number : 8400029, Cleveland
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702NEPTUNE Match Study
- Cleveland Clinic Foundation, Cleveland
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Cleveland Clinic, Cleveland
- The Ohio State University Wexner Medical Center, Columbus
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Nationwide Children's Hospital, Columbus
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.